Navigation Links
Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon

estor Relations,+1-301-251-6003, both of Human Genome Sciences, Inc.

Web site: http://www.hgsi.com/

Company News On-Call: http://www.prnewswire.com/comp/121115.html /

Ticker Symbol: (NASDAQ-NMS:HGSI)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
5. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
6. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
9. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
10. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
11. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
Post Your Comments:
(Date:1/23/2015)... Jan. 23, 2015  Now available for sale, The Armor1 ... that prevents ankle sprains by cushioning the ankle from ... securely around the outside of any shoe type and ... while still offering protection against sprains. With customers in ...
(Date:1/23/2015)... N.J. , Jan. 23, 2015  CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce ... announced the receipt of $385,642, net of transaction ... of the Technology Business Tax Certificate Transfer Program ...
(Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
Breaking Medicine Technology:The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
(Date:1/22/2015)... The federal court overseeing thousands of vaginal mesh ... District of West Virginia has upheld a $2 million verdict ... trial. In an Order dated January 21st, the Court denied ... C.R. Bard had not proven a miscarriage of justice. (Cisson ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... 22, 2015 A study recently ... flagship journal Medicine & Science in Sports & ... may help reduce gastrointestinal (GI) problems associated with ... Participants in the double-blind, placebo-controlled study took 10 ...
(Date:1/22/2015)... 22, 2015 Four years since the release of ... coincided with the marriage of Avasa & Matthew Love – the ... is scheduled for release through White Swan Records on February 24, ... is a sacred path available to all of us to walk ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... /PRNewswire-FirstCall/ - AlphaRx (OTC BB:ALRX -,News), an ... to develop novel formulations of drugs, is ... Indaflex(TM), its topical NSAID,(Non-Steroidal Anti-Inflammatory Drug) formulation, ... ("Cypress,) (NASDAQ: CYPB )., In ...
... May 12 portionpals(R), an innovative,weight-loss tool is proud ... mark,this past Saturday, May 10th, in less than its ... alternative among consumers,looking for a healthy way to lose ... share in a multi-billion dollar industry with no national,distribution ...
... N.J., May 12 Medarex, Inc.,(Nasdaq: MEDX ) announced ... Including a gain of $151.8 million, or $1.19 per ... stock in February 2008, Medarex,s,net income for the quarter ended ... compared to a net income of $110.3 million, or $0.88,per ...
... MedCath Corporation,(Nasdaq: MDTH ), a health care ... the diagnosis and treatment of cardiovascular,disease, today announced ... Interim Chief Financial Officer, has been named,Senior Vice-President, ... new role, Art will continue to oversee and ...
... The American,Veterinary Medical Association (AVMA) has revised its ... veterinarians with additional guidance,for managing pain associated with ... 2008, does not dictate that practitioners use any,particular ... provides some,basic recommendations for consideration by practitioners when ...
... Authority Over Tobacco, WASHINGTON, May 9 ... today announces their,support of H.R. 1108, "The Family ... FDA regulatory authority over tobacco products., "We ... year.,H.R. 1108 has broad bi-partisan support and could ...
Cached Medicine News:Health News:AlphaRx's Indaflex(TM) Continues its Clinical Development 2Health News:Diet Industry Newcomer Hits the 1 Million Unit Mark 2Health News:Medarex Announces 2008 First Quarter Financial Results 2Health News:Medarex Announces 2008 First Quarter Financial Results 3Health News:Medarex Announces 2008 First Quarter Financial Results 4Health News:Medarex Announces 2008 First Quarter Financial Results 5Health News:Medarex Announces 2008 First Quarter Financial Results 6Health News:Medarex Announces 2008 First Quarter Financial Results 7Health News:Medarex Announces 2008 First Quarter Financial Results 8Health News:MedCath Names Parker to New Finance Post 2Health News:Revised AVMA Policy on Castrating and Dehorning Cattle Provides Additional Guidance for Managing Pain 2
... the only approved radiolucent stand-alone implant that ... the proven reliability of the BAK threaded ... is constructed of radiolucent, carbon-fiber reinforced PEEK-OPTIMA ... visualization, providing a new level of confidence ...
... (bDNA) delivers unmatched precision and reproducibility, so you ... viral load values they can trust.,you detect significant ... critical decision points - without the variability seen ... to choose VERSANT HIV bDNA, consider this: it's ...
... The AMPLICOR HIV-1 MONITOR Test, v1.5, an FDA-approved ... load testing, has been used in the regulatory ... in eight out of 10 clinical laboratories worldwide. ... v1.5 is an in vitro nucleic acid amplification ...
... Recombigen HIV is a single use rapid test, ... plasma, serum and whole blood (venipuncture). Uni-Gold Recombigen ... care settings as an aid in diagnosis of ... use in appropriate multi-test algorithms designed for the ...
Medicine Products: